CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-09-07. AI was used for research and drafting; the existence of all 2 cited sources was verified (1 access-limited, verified via index/summary and marked), followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 3023 · Search date 2026-09-07 · Methodology v1.0

Single-ingredient oral vitamin C supplementation,
does it really help with Prevention of incident pneumonia?

30-Second Summary
C
Evidence Grade C · 50 · Safety caution
The earlier cold/cancer and sepsis verdicts were not reopened.
High oral doses can cause gastrointestinal effects. Trial-specific adverse-event counts remain limited.
What the
research shows
Grade C with 50 points. Two old prevention studies yielded RR 0.46 with a 95% CI of 0.06 to 3.61. Military and low-intake populations cannot be generalized to routine prevention.
What the
ads claim
Broad respiratory-prevention claims should not merge colds, pneumonia, food intake and IV exposure.
*

Useful facts when choosing a product

  • This verdict concerns single-ingredient oral vitamin C and does not automatically include foods, combinations, or intravenous infusion.
  • Trials with different doses, durations, and populations were not treated as interchangeable.
  • High oral doses can cause gastrointestinal effects; caution is warranted with stone risk, kidney disease, or iron overload.
ID

Chamgap Semantic Classification Code

Permanent code issued

S.vitamin-c.oral.pneumonia-incidence.prevent.placebo

Supplements and nutraceuticals > Vitamin C > Oral > Pneumonia incidence > Prevention claim > Placebo

Permanent semantic code issued and separated from pneumonia treatment and intravenous vitamin C. The code identifies the intervention and claim; it never contains the evidence grade, score, or safety result.

Download semantic index (JSON) · Codebook v1

Exact Claim Classification

These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.

Intervention classS · Supplement or nutraceutical
Canonical ingredient or interventionVitamin C
Source or part usedPurified nutrient. Feedstock, manufacturing process and country are unverified; plant part is not applicable.
Formulation or processingSingle-ingredient ascorbic acid supplement; unverified tablet/capsule, salt and excipient details are flagged by study.
RouteOral
Dose1-2 g/day
Duration8-14 weeks
PopulationPhysically stressed or low-intake populations
Effect or conditionPrevention of incident pneumonia
Primary endpointNew pneumonia incidence
ComparatorPlacebo or no supplementation
Duplicate-detection keyvitamin-c|oral|high-stress-low-intake-populations|pneumonia-incidence-prevention|placebo-no-supplement
Gap Measurement · Verdict 3023 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Two old oral prevention studies were reviewed. A 674-person marine-recruit trial covered respiratory illness, but the prespecified status of pneumonia and original event counts and confidence intervals were not verified. Cochrane pooling gave RR 0.46 with a 95% CI of 0.06 to 3.61. Treatment of existing pneumonia, sepsis, and intravenous dosing were excluded.

02

Why this is classified as C (50)

Pneumonia incidence is clinical, but precision is extremely poor and evidence is old and sparse. One strength with EX and B2 limits gives C with 50 points.

Counterpoint. Unverified event data are not the same as an absence of all human research.

Rejudgment record. Independent Codex cross-check — One page, one route, one population, one claim, one principal comparator

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR0Trials conflict in direction
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeEXThe clinical size of the effect could not be judged
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (C).

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Vitamin C prophylaxis in marine recruitsDouble-blind military prophylaxis trial674UnverifiedRespiratory illness;primary pneumonia hierarchy unverifiedOriginal pneumonia event counts/CI not verified;review values not adoptedHistorical oral evidence;no general-population extrapolation
§

Receipt — 2 References

Of 2 cited sources, 1 had limited original-page access (blocked or summary-only) and were verified via index/summary, marked partial; the rest were verified at the original page. As of 2026-09-07.

Pitt HA, Costrini AM. Vitamin C prophylaxis in marine recruits. JAMA. 241(9):908–911. 1979. PMID: 368370; DOI: 10.1001/jama.1979.03290350028016.
partial
Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database Syst Rev. 2021. PMID: 34791642.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none

Cite this verdict

Oral Vitamin C for Preventing Pneumonia—Evidence From Old High-Stress Populations Is Very Uncertain Evidence Grade C card
[Chamgap] Oral Vitamin C for Preventing Pneumonia—Evidence From Old High-Stress Populations Is Very Uncertain — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/oral-vitamin-c-pneumonia-prevention/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.